Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024. In the quarter to June 2026, revenue grew 17.2%, EPS grew 36.4% and free cash flow fell 3.03%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for ten.

618.47 10.13 −1.61%
Market cap
$17.6B
P/E
35.6×
Fwd P/E
26.7×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

35.07 35.87 29.57 30.45
P/S ratio
6.13 6.40 5.10 5.36
P/FCF ratio
21.38 23.76 19.21 21.11
P/Operating CF
58.76 84.10 89.99 92.10
P/B ratio
49.27 35.29 22.83 34.39
EV/Sales
6.06 6.25 4.90 5.22
EV/EBITDA
26.69 28.09 22.19 23.77
EV/FCF
21.12 23.19 18.45 20.56
Current Ratio
0.57 0.74 0.85 0.73
Net Debt/EBITDA
(1.92) (3.10) (4.40) (3.27)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
2.85% 2.79% 3.38% 3.28%
Free Cash Flow Yield
4.68% 4.21% 5.21% 4.74%
Free Cash Flow per Share
8.37 6.52 5.10 4.90
Book value per Share
10.44 15.91 21.03 15.40
Free Cash Flow
235.50 188.12 144.97 138.10
EV/EBIT
28.19 29.56 23.30 24.90
Other line items

Show all line items

Columns are period end dates